Absence of human T-lymphotropic virus types I and II infection in an Ontario hemophilia population.

Transfusion

Immunology Group, John Roberts Research Institute, University of Western Ontario, London, Canada.

Published: September 1992

Two hundred ninety-three serum samples from Ontario hemophiliacs and 200 samples from human immunodeficiency virus-positive blood donors were screened for the presence of antibodies to human T-lymphotropic virus type I (HTLV-I) by enzyme-linked immunosorbent assay, radioimmunoassay, and Western blot techniques. None of the serum samples provided unequivocal positive results, but several samples gave inconclusive results. Of the hemophiliacs with inconclusive serologic results from whom peripheral blood lymphocyte DNA could be obtained, all were negative for HTLV-I and HTLV type II (HTLV-II) sequences as determined by polymerase chain reaction (PCR). PCR was also performed on a lymph node biopsy sample taken from a hemophiliac who developed a rare T-cell lymphoma; the sample was negative for HTLV-I and -II sequences. These results indicate that Ontario hemophiliacs have not been exposed to HTLV-I or HTLV-II.

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1537-2995.1992.32692367193.xDOI Listing

Publication Analysis

Top Keywords

human t-lymphotropic
8
t-lymphotropic virus
8
serum samples
8
ontario hemophiliacs
8
negative htlv-i
8
absence human
4
virus types
4
types infection
4
infection ontario
4
ontario hemophilia
4

Similar Publications

Decoding the molecular complexity of viruses in human cancer: insights into host cell infection, oncogenesis, and therapeutic prospects.

Crit Rev Microbiol

March 2025

Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Bhubaneswar, Odisha, India.

Infections account for approximately 15% of human cancers worldwide. Viruses are the most predominant infectious agents and can infect and alter various types of human cells thereby leading to the development of various forms of cancer. Current studies have reported that Epstein-Barr virus (EBV), hepatitis B virus (HBV), hepatitis C virus (HBC), human papillomavirus (HPV), Kaposi's sarcoma-associated herpesvirus (KSHV), human T-lymphotropic virus 1 (HTLV-1), Markel cell polyomavirus (MCPyV), and BK polyomavirus are the most important oncogenic viruses that are directly involved in the initiation and progression of cancer.

View Article and Find Full Text PDF

Background: A 52-year-old woman with multiple myeloma and asymptomatic human T lymphotropic virus (HTLV)-I infection underwent an autologous stem cell transplantation. Eighteen days after transplantation, she developed fever, headache, ataxia, and tremors. Coinfection of human herpesvirus 6 and HTLV-I encephalitis was diagnosed.

View Article and Find Full Text PDF

Viral oncogenesis of δ-retroviruses, HTLV-1 and BLV, and recent advances in its diagnosis.

Virology

February 2025

Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-8556, Japan. Electronic address:

The δ-retrovirus genus includes human T-cell leukemia viruses (HTLV-1, HTLV-2, HTLV-3), simian T-lymphotropic viruses (STLV), and bovine leukemia viruses (BLV), which establish lifelong, typically asymptomatic, infections. However, HTLV-1 and BLV can lead to leukemia or lymphoma in 2-5% of infected hosts after prolonged latency. HTLV-1, the first identified human oncogenic retrovirus, drives T-cell leukemia/lymphoma via cell-intrinsic mechanisms.

View Article and Find Full Text PDF

Long-term kinetics of proviral load in HTLV-1 carriers: defining risk for the development of adult T-cell leukemia/lymphoma.

Biomark Res

February 2025

Division of Hematopoietic Disease Control, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-Ku, Tokyo, 108-8639, Japan.

Background: Assessment of adult T-cell leukemia/lymphoma (ATL) development among human T-lymphotropic virus 1 (HTLV-1)-infected individuals (carriers) constitute a significant issue. A high HTLV-1 proviral load (PVL) in carriers has been used as a risk factor for ATL development and PVLs are considered to remain unchanged over time among carriers.

Methods: This single-center analysis used a cohort from a prospective observational study of HTLV-1 carriers in Japan (JSPFAD).

View Article and Find Full Text PDF

Persistent oncogenic HPV infection is strongly associated with cervical cancer. Studies have suggested a higher prevalence of HPV in women living with HTLV-1. This study aimed to determine whether HTLV-1 infection is associated with cervicovaginal HPV infection and to characterize HPV types according to oncogenic risk.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!